Skip to main content

Processa Pharmaceuticals, Inc DEF 14A, filed Oct 22, 2026

Processa Pharmaceuticals, Inc. (PCSA)

DEF 14A 2026-10-22 For: 2026-11-30
View Original
Added on October 23, 2026

About this DEF 14A

Processa Pharmaceuticals, Inc filed this DEF 14A on October 22, 2026.

Processa Pharmaceuticals, Inc. completed its merger with Vidya Therapeutics, Inc. on July 28, 2026, and will ask stockholders on November 30, 2026 to approve a reverse stock split at a ratio of not less than 1-for-3 and not more than 1-for-9. AI summary